approval · primary record
LEBRIKIZUMAB-LBKZ
FDA · BLA · 2026-06-09
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-06-09 |
| Brand | EBGLYSS |
| Sponsor | ELI LILLY AND CO |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:54.111Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LEBRIKIZUMAB-LBKZ:2026-06-09
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.